Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: M. Ramle who wrote (1142)	9/9/1998 7:24:00 PM
From: Ed Ajootian	Read Replies (1) \| Respond to of 10280

Mazen, I don't feel it is over-valued. I feel that it is approaching fair value. Once they start actually marketing drugs, I feel that the stock is really gonna start acting even more schizoid than it has recently. The investors who are looking for instant commercial success will no doubt bail, while the ones focused on the pipeline will be buying. I really hope you are right and I'm all wrong! I still own a ton of the stock. I'm still intrigued by SEPR options. A kind soul gave me an excellent site for SEPR options quotes, as follows: cboe.pcquote.com Check out another spread I'm thinking of: Buy the April 45's & sell the April 65's, for a net debit of just about $8.50! Another relatively low-risk shot at a double over the next 7 months.